# Study of LRG-002 Hard Capsules (Lek d.d., Slovenia) Used in the Prophylaxis of Antibiotic-associated Diarrhea in Adults.

> **NCT04321460** · PHASE3 · COMPLETED · sponsor: **Sandoz** · enrollment: 520 (actual)

## Conditions studied

- Antibiotic-associated Diarrhea

## Interventions

- **DRUG:** LRG-002
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04321460
- **Lead sponsor:** Sandoz
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-01
- **Primary completion:** 2021-01-04
- **Final completion:** 2021-01-04
- **Target enrollment:** 520 (ACTUAL)
- **Last updated:** 2022-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04321460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04321460, "Study of LRG-002 Hard Capsules (Lek d.d., Slovenia) Used in the Prophylaxis of Antibiotic-associated Diarrhea in Adults.". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04321460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*